Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001567619-21-019403

Director sold 13,354 shares at $19.50 ($260,403)

From the SEC's structured data for this filing

Trades in this filing

Fust Matthew K · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-11-04 Sale : show line 1 in the form −13,354 $19.50 $260,403 31,500 D
Open-market sales · 13,354 sh · avg $19.50 · $260,403
Loading xslF345X03/doc1.xml…